LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 18.61

Change

+0.09 (+0.49)%

Market Cap

CAD 0.22B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.39 (-0.88%)

CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

+0.08 (+0.73%)

CAD 1.83B
XIT:CA iShares S&P/TSX Capped Informa..

+0.05 (+0.07%)

CAD 0.72B
HTA:CA Harvest Tech Achievers Growth ..

-0.18 (-1.01%)

CAD 0.59B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.01 (+0.04%)

CAD 0.57B
TXF:CA First Asset Tech Giants Covere..

+0.02 (+0.10%)

CAD 0.57B
XHC:CA iShares Global Healthcare (CAD..

+0.35 (+0.56%)

CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.08 (+0.27%)

CAD 0.35B
CWW:CA iShares Global Water Common Cl..

-0.52 (-0.84%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

-0.11 (-0.60%)

CAD 0.29B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.37% 40% F 24% F
Dividend Return 0.99% 41% F 52% F
Total Return -2.39% 43% F 26% F
Trailing 12 Months  
Capital Gain -12.26% 11% F 13% F
Dividend Return 2.40% 58% F 44% F
Total Return -9.85% 11% F 13% F
Trailing 5 Years  
Capital Gain -11.86% 11% F 19% F
Dividend Return 34.43% 76% C+ 79% B-
Total Return 22.57% 20% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain -0.33% 20% F 28% F
Dividend Return 0.83% 14% F 25% F
Total Return 1.16% 50% F 41% F
Risk Return Profile  
Volatility (Standard Deviation) 6.95% 97% N/A 84% B
Risk Adjusted Return 11.91% 17% F 27% F
Market Capitalization 0.22B 65% D 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.